Rejecting FDA Advice, ACIP Defers J&J COVID Vaccine Blood Clot Decision Until It Gets More Data

 
• By Derrick Gingery
Janssen vaccine and name (shutterstock)
The CDC's advisory committee is hoping a continued pause will allow for better data about the potential risks of Janssen's covid vaccine. • Source: Shutterstock

More from Vaccines

More from Pink Sheet